SLITRK5 is a cellular protein whose normal function appears to suppress bone formation and could be a potential new target for the treatment ofosteoporosis, according to a collaborative study conducted by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Cells manifesting the SLITRK5 protein are marked with magenta (left) and a bone-forming osteoblast marker in green (center). These markers were observed in the cancellous bone in the medulla space (top) or on the outer layer covering the bone (bottom). The overlap between these two markers (right) shows that SLITRK5 is found in bone-forming osteoblasts but not in other cell types, helping to make SLITRK5 a target for skeletal disease treatment. Credit: Dr. Matthew Greenblatt and Dr. Jun Sun
There Research was published in the scientific journal Nature Communications.
Read Also
- Arcom challenges Twitter and expresses “deep concern” over fake news and online hate Nov 21, 2022
- F1, an unexpected Ferrari in the Netherlands. But on the Verstappen pass it dominates Sep 3, 2021
- Control your smartphone with your PC : the application “Your phone” acquires a new interesting function Jun 8, 2020
- Sotheby’s sells original internet code for 5.4 million Jun 30, 2021
- 40,000 units of the Xiaomi Mi Mix Fold sold out in a minute Apr 17, 2021
- The possible eleven of Spain to visit Kosovo Sep 7, 2021
- Twitter: Elon Musk Considers ‘Blanket Amnesty’ For Suspended Accounts Nov 23, 2022